Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

MDT, CLNO, VR, NHPR, ALR - Stock Report! March 25th 2011



FREE Daily Stock Alerts From


Medtronic, Inc. (NYSE:MDT) announced that the U.S. Food & Drug Administration (FDA) has approved its Consulta® and Syncra™ cardiac resynchronization therapy-pacemaker (CRT-P) systems. Consulta is the first CRT-P that includes Medtronic‘s exclusive OptiVol® Fluid Status Monitoring, which identifies patients at risk for worsening heart failure before symptoms develop.3-9 Additionally, both Consulta and Syncra are the first CRT-Ps that include Leadless ECG Waveform, which together with the Medtronic CareLink® Network device data monitoring system, offer the possibility of remote follow-up in heart failure patients implanted with these devices. Shipments of Consulta and Syncra will begin immediately.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. Medtronic, Inc. was founded in 1949 and is headquartered in Minneapolis, Minnesota.


Biomass, a renewable energy source, is biological material from living, or recently living organisms, such as wood, waste, (hydrogen) gas, and alcohol fuels.

Example of Successful Wood-Waste-to-Energy Applications: Wood-Fired Cogeneration Provides Reliable Off-Grid Power for Maryland Correctional Facility

A Maryland Department of Corrections facility has cut its fuel costs by 63 percent by producing its own power using a wood-chip-fired cogeneration plant.

Read more at: